title: Cardiovascular risk associated with hormone replacement therapy: some critical questions about the type of estrogen used in most clinical trials.
authors.forename: M T Ravi
authors.initials: MT
authors.lastname: Subbiah
mesh_terms: D000367:Age Factors; D000368:Aged; D002626:Chemistry, Pharmaceutical; D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000453:epidemiology* / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D015914:Estrogen Replacement Therapy / Q000009:adverse effects* / Q000379:methods; D004967:Estrogens / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015994:Incidence; D008593:Menopause; D008875:Middle Aged; D011379:Prognosis; D018570:Risk Assessment
chemical_list: D004967:Estrogens